Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Abroad (travel likely)RecruitingPHASE3
Conditions
Gastric Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fujian cancer hospital, Fuzhou, Fujian, China
Contact: Study coordinator (Lin ron bo, bachelor)
Study leads
Rong bo Lin, bachelor
Principal Investigator
Fujian Cancer Hospital